Filing Details
- Accession Number:
- 0001209191-17-058761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-02 14:13:10
- Reporting Period:
- 2017-11-01
- Accepted Time:
- 2017-11-02 14:13:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1175505 | Five Prime Therapeutics Inc | FPRX | Pharmaceutical Preparations (2834) | 260038620 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238325 | R William Ringo | Two Corporate Drive South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-01 | 600 | $11.65 | 600 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-01 | 600 | $45.33 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-11-01 | 600 | $0.00 | 600 | $11.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,600 | 2024-09-30 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 15, 2016.
- This option is fully vested and immediately exercisable.